Bal Pharma [BALPHARMA] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Bal Pharma Ltd.

NSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Bal Pharma Ltd. wins in 7 metrics, Sun Pharmaceutical Industries Ltd. wins in 13 metrics, with 0 ties. Sun Pharmaceutical Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bal Pharma Ltd. Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) 15.34 36.73 Bal Pharma Ltd.
Price-to-Book Ratio 1.57 5.15 Bal Pharma Ltd.
Debt-to-Equity Ratio 197.73 6.68 Sun Pharmaceutical Industries Ltd.
PEG Ratio 0.06 3.59 Bal Pharma Ltd.
EV/EBITDA 11.21 23.61 Bal Pharma Ltd.
Profit Margin (TTM) 2.63% 19.21% Sun Pharmaceutical Industries Ltd.
Operating Margin (TTM) 7.20% 26.17% Sun Pharmaceutical Industries Ltd.
EBITDA Margin (TTM) 7.20% 26.17% Sun Pharmaceutical Industries Ltd.
Return on Equity 9.32% 15.08% Sun Pharmaceutical Industries Ltd.
Return on Assets (TTM) 2.15% 11.87% Sun Pharmaceutical Industries Ltd.
Free Cash Flow (TTM) $15.28M $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield 1.63% 0.97% Bal Pharma Ltd.
1-Year Return -16.65% 7.10% Sun Pharmaceutical Industries Ltd.
Price-to-Sales Ratio (TTM) 0.40 7.05 Bal Pharma Ltd.
Enterprise Value $2.70B $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 0.87 6.66 Bal Pharma Ltd.
Gross Profit Margin (TTM) 47.36% 80.96% Sun Pharmaceutical Industries Ltd.
Revenue per Share (TTM) $184 $237 Sun Pharmaceutical Industries Ltd.
Earnings per Share (Diluted) $5.09 $45.46 Sun Pharmaceutical Industries Ltd.
Beta (Stock Volatility) 0.35 0.11 Sun Pharmaceutical Industries Ltd.

Bal Pharma Ltd. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

BALPHARMA
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bal Pharma Ltd.1.84%3.22%10.10%31.09%17.86%20.21%
Sun Pharmaceutical Industries Ltd.-0.09%0.96%-3.84%1.28%0.50%4.93%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bal Pharma Ltd.-16.65%-2.22%-11.24%-2.11%212.28%161.58%
Sun Pharmaceutical Industries Ltd.7.10%82.23%170.41%143.23%656.74%2,541.29%

Performance & Financial Health Analysis: Bal Pharma Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricBALPHARMASUNPHARMA
Market Information
Market Cap i₹1.24B₹3.88T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i7,9223,903,142
90 Day Avg. Volume i12,0553,253,866
Last Close₹87.78₹1,806.00
52 Week Range₹60.00 - ₹106.50₹1,548.00 - ₹1,916.60
% from 52W High-17.58%-5.77%
All-Time High₹167.90 (Jan 11, 2016)₹1,960.35 (Sep 30, 2024)
% from All-Time High-47.72%-7.87%
Growth Metrics
Quarterly Revenue Growth0.20%0.14%
Quarterly Earnings Growth2.70%0.16%
Financial Health
Profit Margin (TTM) i0.03%0.19%
Operating Margin (TTM) i0.07%0.26%
Return on Equity (TTM) i0.09%0.15%
Debt to Equity (MRQ) i197.736.68
Cash & Liquidity
Book Value per Share (MRQ)₹49.68₹324.46
Cash per Share (MRQ)₹5.74₹115.87
Operating Cash Flow (TTM) i₹74.55M₹110.84B
Levered Free Cash Flow (TTM) i₹72.15M₹109.29B
Dividends
Last 12-Month Dividend Yield i1.63%0.97%
Last 12-Month Dividend i₹1.20₹16.50

Valuation & Enterprise Metrics Analysis: Bal Pharma Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricBALPHARMA (Apr 24, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i15.3436.73
Forward P/E iN/A29.48
PEG Ratio i0.063.59
Price to Sales (TTM) i0.407.05
Price to Book (MRQ) i1.575.15
Market Capitalization
Market Capitalization i₹1.24B₹3.88T
Enterprise Value i₹2.70B₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i0.876.66
Enterprise to EBITDA i11.2123.61
Risk & Other Metrics
Beta i0.350.11
Book Value per Share (MRQ) i₹49.68₹324.46

Financial Statements Comparison: Bal Pharma Ltd. vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBALPHARMA (2025)SUNPHARMA (2025)
Revenue/Sales i2.94B520.41B
Cost of Goods Sold i1.61B121.98B
COGS % of Revenue i54.8%23.4%
Gross Profit i1.33B398.44B
Gross Margin i45.2%76.6%
Research & Development iN/AN/A
Operating Income (EBIT) i201.02M125.81B
Operating Margin i6.8%24.2%
EBITDA i294.33M167.25B
EBITDA Margin i10.0%32.1%
Pre-Tax Income i51.37M137.52B
Pre-Tax Income % of Revenue i1.7%26.4%
Income Tax i-20.99M27.72B
Income Tax % of Revenue i-0.7%5.3%
Net Income (Profit) i72.37M109.65B
Profit Margin i2.5%21.1%

Balance Sheet & Liquidity Metrics

MetricBALPHARMA (2025)SUNPHARMA (2025)
Cash & Equivalents i17.52M102.69B
Total Current Assets i2.35B526.24B
Total Current Assets % of Revenue i79.8%101.1%
Total Current Liabilities i2.20B181.94B
Total Current Liabilities % of Revenue i74.6%35.0%
Long-Term Debt i326.90M3.58B
Long-Term Debt % of Revenue i11.1%0.7%
Total Shareholders Equity i774.04M724.86B
Retained Earnings i273.10M578.62B
Retained Earnings % of Revenue i9.3%111.2%
Property, Plant & Equipment i709.91M100.36B

Cash Flow Statement Comparison

MetricBALPHARMA (2025)SUNPHARMA (2025)
Operating Cash Flow i74.55M110.84B
Operating Cash Flow % of Revenue i2.5%21.3%
Capital Expenditures i-187.87M-20.68B
Free Cash Flow i15.28M119.44B
FCF Margin i0.5%23.0%
Debt Repayment i-49.49M-43.44B
Common Stock Repurchase iN/A-29.00B

Short Interest & Institutional Ownership Analysis

MetricBALPHARMASUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i15.92M2.40B
Float Shares i5.45M1.07B
% Held by Insiders i65.53%55.62%
% Held by Institutions i0.00%28.69%
% Held by Public i34.47%15.69%

Dividend Analysis & Yield Comparison: Bal Pharma Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricBALPHARMASUNPHARMA
Last 12-Month Dividend i₹1.20₹16.50
Last 12-Month Dividend Yield i1.63%0.97%
3-Year Avg Annual Dividend i₹1.13₹17.33
3-Year Avg Dividend Yield i1.14%0.51%
3-Year Total Dividends i₹3.40₹52.00
Ex-Dividend DateSep 18, 2025Feb 05, 2026